Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Search Results
Search Results 241 – 260 of 3231
Antiretroviral Drug Regimens and Pregnancy Outcomes
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-regimens-maternal-neonatal-outcomes
Preventing HIV Transmission During Infant Feeding
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/preventing-transmission-infant-feeding
Drug Name Abbreviations
https://clinicalinfo.hiv.gov/guidelines/perinatal/appendix-a-drug-name-abbreviations
General Terms
https://clinicalinfo.hiv.gov/guidelines/perinatal/appendix-a-acronyms-general-terms
Study and Trial Names
https://clinicalinfo.hiv.gov/guidelines/perinatal/appendix-a-study-trials-names
Updates to Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the U.S.
https://clinicalinfo.hiv.gov/news/recommendations-use-arv-drugs-during-pregnancy-interventions-reduce-perinatal-hiv-transmission
Actualizaciones a las Recomendaciones para el Uso de Antirretrovirales durante el embarazo e intervenciones para reducir la Transmisión Perinatal del VIH en los Estados Unidos
https://clinicalinfo.hiv.gov/news/recommendations-use-arv-drugs-during-pregnancy-interventions-reduce-perinatal-hiv-transmission
Gentamicin
https://clinicalinfo.hiv.gov/drugs/gentamicin/patient
Gentamicina
https://clinicalinfo.hiv.gov/drugs/gentamicin/patient
Gentamicin
https://clinicalinfo.hiv.gov/drugs/gentamicin/fda-label
Lenacapavir
https://clinicalinfo.hiv.gov/drugs/lenacapavir/patient
Lenacapavir
https://clinicalinfo.hiv.gov/drugs/lenacapavir/patient
Lenacapavir
https://clinicalinfo.hiv.gov/drugs/lenacapavir/fda-label
Doxycycline
https://clinicalinfo.hiv.gov/drugs/doxycycline/patient
Doxiciclina
https://clinicalinfo.hiv.gov/drugs/doxycycline/patient
Erythromycin
https://clinicalinfo.hiv.gov/drugs/erythromycin/fda-label
Erythromycin
https://clinicalinfo.hiv.gov/drugs/erythromycin/patient
Eritromicina
https://clinicalinfo.hiv.gov/drugs/erythromycin/patient
Pneumococcal Conjugate Vaccines
https://clinicalinfo.hiv.gov/drugs/pneumococcal-conjugate-vaccines/patient
Vacunas antineumocócicas conjugadas
https://clinicalinfo.hiv.gov/drugs/pneumococcal-conjugate-vaccines/patient

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page ›
  • Last page »

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.